Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset

Rheumatology

Volumn 47, Issue 4, 2008, Pages 526-529

  Manlhiot, C ^a   Liang, L ^a   Tran, D ^a   Bitnun, A ^a   Tyrrell, P N ^a   Feldman, Brian M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autoimmunity; Idiopathic inflammatory myopathies; Infection; Juvenile dermatomyositis; Seasons

Indexed keywords

ANAMNESIS; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SEASONAL VARIATION; SYMPTOMATOLOGY; CANADA; COMMUNICABLE DISEASE; MICROBIOLOGY; RESPIRATORY TRACT INFECTION; SEASON;

CHILD; COHORT STUDIES; COMMUNICABLE DISEASES; DERMATOMYOSITIS; FEMALE; HUMANS; MALE; ONTARIO; RESPIRATORY TRACT INFECTIONS; SEASONS;

EID: 43049178490     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken038     Document Type: Article

References (37)

1. Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: Results from a nation-wide study. Br J Rheumatol 1995;34:732-6.
2. Compeyrot-Lacassagne S, Feldman BM. Inflammatory myopathies in children. Pediatr Clin North Am 2005;52:493-520, vi-vii.
3. Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002;28:833-57.
4. Reed AM, Stirling JD. Association of the HLA-DQA10501 allele in multiple racial groups with juvenile dermatomyositis. Hum Immunol 1995;44:131-5.
5. Shamim EA, Rider LG, Miller FW. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2000;12:482-91.
6. West JE, Reed AM. Analysis of HLA-DM polymorphism in juvenile dermatomyositis (JDM) patients. Hum Immunol 1999;60:255-8.
7. Haegerty AM, Byrom NP, Cookson JB. Acute dermatomyositis associated with a staphylococcal infection. Postgrad Med J 1981;57:796-8.
8. Hendrickx GF, Verhage J, Jennekens FG, van Knapen F. Dermatomyositis and toxoplasmosis. Ann Neurol 1979;5:393-5.
9. Lane S, Doherty M, Powell RJ. Dermatomyositis following chronic staphylococcal joint sepsis. Ann Rheum Dis 1990;49:405-6.
10. Lewkonia RM, Horne D, Dawood MR. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995;21:430-2.
11. Ogra PL, Chiba Y, Ogra SS, Dzierba JL, Herd JK. Rubella-virus infection in juvenile rheumatoid arthritis. Lancet 1975;1:1157-61.
12. Schiraldi O, Iandolo E. Polymyositis accompanying coxsackie virus B2 infection. Infection 1978;6:32-4.
13. Travers RL, Hughes GR, Cambridge G, Sewell JR. Coxsackie B neutralisation titres in polymyositis/dermatomyositis. Lancet 1977;1:1268.
14. Behan WM, Behan PO, Draper IT, Williams H. Does Toxoplasma cause polymyositis? Report of a case of polymyositis associated with toxoplasmosis and a critical review of the literature. Acta Neuropathol 1983;61:246-52.
15. Middleton PJ, Alexander RM, Szymanski MT. Severe myositis during recovery from influenza. Lancet 1970;2:533-5.
16. Pachman LM, Hayford JR, Hochberg MC et al. New-onset juvenile dermatomyositis: Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum 1997;40:1526-33.
17. Pachman LM, Lipton R, Ramsey-Goldman R et al. History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 2005;53:166-72.
18. Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986;29:1365-70.
19. Kalliomaki JL, Halonen P. Antibody levels to parainfluenza, herpes simplex, varicellazoster, cytomegalo virus, and measles virus in patients with connective tissue diseases. Ann Rheum Dis 1972;31:192-5.
20. Koch M, Brody JA, Nemo GJ, Sever JL. Antibody levels to parainfluenza, rubella, measles, and influenza A virus in children with polymyositis. Arthritis Rheum 1975;18:353-5.
21. Leff RL, Love LA, Miller FW et al. Viruses in idiopathic inflammatory myopathies: Absence of candidate viral genomes in muscle. Lancet 1992;339:1192-5.
22. Mamyrova G, Rider LG, Haagenson L, Wong S, Brown KE. Parvovirus B19 and onset of juvenile dermatomyositis. J Am Med Assoc 2005;294:2170-1.
23. Phillips PE. Virologic studies in rheumatoid arthritis and other connective tissue diseases. J Exp Med 1971;134(3 Pt 2):313s-9s.
24. Bowles NE, Dubowitz V, Sewry CA, Archard LC. Dermatomyositis, polymyositis, and coxsackie-B-virus infection. Lancet 1987;1:1004-7.
25. Magid SK, Kagen LJ. Serologic evidence for acute toxoplasmosis in polymyositisdermatomyositis. Increased frequency of specific anti-toxoplasma IgM antibodies. Am J Med 1983;75:313-20.
26. Hengstman GJ, van Venrooij WJ, Vencovsky J, Moutsopoulos HM, van Engelen BG. The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient. Ann Rheum Dis 2000;59:141-2.
27. Manta P, Kalfakis N, Vassilopoulos D. Evidence for seasonal variation in polymyositis. Neuroepidemiology 1989;8:262-5.
28. Mayes MD. Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 1999;107(Suppl 5):743-8.
29. Schwarz A, Bhardwaj R, Aragane Y et al. Ultraviolet-B-induced apoptosis of keratinocytes: Evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 1995;104:922-7.
30. Schwarz A, Stander S, Berneburg M et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol 2002;4:26-31.
31. Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Influenza and pneumonia hospitalizations in Ontario: A time-series analysis. Epidemiol Infect 2004;132:1167-74.
32. Thomas MK, Majowicz SE, MacDougall L et al. Population distribution and burden of acute gastrointestinal illness in British Columbia, Canada. BMC Public Health 2006;6:307.
33. Upshur RE, Moineddin R, Crighton E, Kiefer L, Mamdani M. Simplicity within complexity: Seasonality and predictability of hospital admissions in the province of Ontario 1988-2001, a population-based analysis. BMC Health Serv Res 2005;5:13.
34. Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol 1996;23:1794-7.
35. Martini A, Ravelli A, Albani S et al. Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5M protein and human skeletal myosin. J Pediatr 1992;121(5 Pt 1):739-42.
36. Massa M, Costouros N, Mazzoli F et al. Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis Rheum 2002;46:3015-25.
37. McCann LJ, Juggins AD, Maillard SM et al. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)-clinical characteristics of children recruited within the first 5 yr. Rheumatology 2006;45:1255-60.